Jenburkt Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 4, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	5,079	4,217	4,465	3,043	2,939	2,601
Market Cap Growth	5.36%	-5.56%	46.74%	3.52%	13.02%	42.23%
Enterprise Value	4,573	4,137	3,709	2,488	2,474	2,149
Last Close Price	1150.90	955.45	998.56	668.58	633.75	526.89
PE Ratio	14.62	12.14	13.93	11.71	11.95	11.66
PS Ratio	2.84	2.36	2.94	2.14	2.15	2.10
PB Ratio	2.58	2.14	2.60	2.10	2.40	2.22
P/TBV Ratio	2.58	2.14	2.60	2.11	2.40	2.22
P/FCF Ratio	39.67	32.93	54.50	54.63	19.66	41.83
P/OCF Ratio	19.15	15.90	16.00	37.46	17.24	28.05
EV/Sales Ratio	2.55	2.31	2.44	1.75	1.81	1.73
EV/EBITDA Ratio	8.46	7.66	9.33	7.67	8.28	8.04
EV/EBIT Ratio	8.98	8.12	9.84	8.08	8.78	8.45
EV/FCF Ratio	35.71	32.31	45.28	44.68	16.55	34.56
Debt / Equity Ratio	0.01	0.01	0.02	-	0.02	0.06
Debt / EBITDA Ratio	0.05	0.05	0.10	-	0.10	0.25
Debt / FCF Ratio	0.19	0.19	0.48	-	0.20	1.09
Net Debt / Equity Ratio	-0.26	-0.26	-0.11	-0.51	-0.38	-0.34
Net Debt / EBITDA Ratio	-0.94	-0.94	-0.48	-2.28	-1.56	-1.49
Net Debt / FCF Ratio	-3.95	-3.95	-2.35	-13.28	-3.11	-6.41
Asset Turnover	0.85	0.85	0.84	0.93	0.96	0.94
Inventory Turnover	2.87	2.87	3.53	3.71	3.71	3.67
Quick Ratio	3.35	3.35	2.39	6.01	4.48	3.00
Current Ratio	4.11	4.11	3.00	6.70	5.15	3.57
Return on Equity (ROE)	18.84%	18.84%	20.25%	19.43%	20.52%	20.66%
Return on Assets (ROA)	15.08%	15.08%	13.04%	12.54%	12.37%	12.04%
Return on Invested Capital (ROIC)	23.67%	25.44%	24.19%	30.98%	27.52%	29.42%
Return on Capital Employed (ROCE)	25.10%	25.10%	21.20%	20.70%	22.40%	20.90%
Earnings Yield	6.84%	8.24%	7.18%	8.54%	8.37%	8.57%
FCF Yield	2.52%	3.04%	1.84%	1.83%	5.08%	2.39%
Dividend Yield	1.68%	-	1.80%	2.29%	2.27%	2.28%
Payout Ratio	22.86%	22.86%	21.15%	24.32%	22.35%	20.99%
Buyback Yield / Dilution	0.00%	0.00%	-	3.34%	0.52%	-
Total Shareholder Return	1.68%	0.00%	1.80%	5.63%	2.79%	2.28%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.